Home » Core One Labs Inc. Announces Initial Agreement for Potential Sale of Proprietary Biosynthetic Psilocybin, Facilitating Entry into the International Market Seite 1

Core One Labs Inc. Announces Initial Agreement for Potential Sale of Proprietary Biosynthetic Psilocybin, Facilitating Entry into the International Market Seite 1

by admin
Core One Labs Inc. Announces Initial Agreement for Potential Sale of Proprietary Biosynthetic Psilocybin, Facilitating Entry into the International Market Seite 1

VANCOUVER, BC / ACCESSWIRE / December 8, 2023 / Core One Labs Inc. (CSE:COOL)(OTCQB:CLABF)(Frankfurt:LD6) (WKN:A3CSSU) (the “Company” or “Core One”) is pleased to announce the signing of an Initial Agreement (the “Agreement”) with Cube Psytech Corp. …

VANCOUVER, BC / ACCESSWIRE / December 8, 2023 / Core One Labs Inc. (CSE:COOL)(OTCQB:CLABF)(Frankfurt:LD6)
(WKN:A3CSSU) (the “Company” or “Core One“) is pleased to announce the signing of an Initial Agreement (the “Agreement“) with Cube Psytech Corp.
(“Cube Psytech“) marking a significant step towards exploring the potential sale of biosynthetically produced psilocybin, or the licensing of its proprietary method for
biosynthetic psilocybin production technology. This Agreement with Cube Psytech could set the stage for Core One products to enter the international market.

Cube Psytech, is a Canadian bio-pharmaceutical and biotechnology company focused on psilocybin and psilocin research and development programs designed to create innovative psilocybin and psilocin
drugs and protocols for clinical trials and patient prescribed uses globally.

See also  Paraguay is bidding for Asuncion as the host of the 2027 Pan American Games

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy